BrightGene Bio-Medical Technology Co.,Ltd.

About BrightGene Bio-Medical Technology Co.,Ltd.

BrightGene Bio-medical Technology Co Ltd is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special generic APIs and FDFs with primary strategic focus on the regulated market. 

We have an exciting and very promising innovative pipeline including immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis....

  • CN
  • 2015
    On CPHI since
Contact info
  • Room C26-C27, Suzhou biological nano-technology park, No.218 Xinghu Street, 215123, Suzhou, China

Products from BrightGene Bio-Medical Technology Co.,Ltd. (50)

  • MMAF

    Product MMAF

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • MMAE

    Product MMAE

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • Maytansinol

    Product Maytansinol

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • DM-4

    Product DM-4

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • DM-1

    Product DM-1

    • Status: Validated • Usage:  Antibody-drug Conjugate
  • SGB

    Product SGB

    • Status: Commercial • Usage:  For Saxagliptin
  • SGA

    Product SGA

    • Status: Commercial • Usage:  For Saxagliptin
  • Ascomycin

    Product Ascomycin

    • Status: DMF No.: 029433 • Usage: Oncology
  • Pneumocandin B0

    Product Pneumocandin B0

    • Status: DMF Ready • Usage: For Caspofungin
  • Echinocandin B0

    Product Echinocandin B0

    • Status: DMF Ready • Usage: For Anidulafungin
  • POB

    Product POB

    • Status: DMF Ready • Usage: For Posaconazole
  • POA

    Product POA

    • Status: DMF Ready • Usage: For Posaconazole